Dr. Sandeep Kumar received his doctoral degree from New Delhi, India. He worked on several underlying mechanisms of hypersensitive immune reactions linked with food including identification of several allergens and the role of cytokines and transcription factors in allergy. Further, he studied role of nanoparticles in allergic manifestations and therapeutics. After gaining a basic in Immunology Dr. Kumar moved to learn basic cancer biology for his long term goal. He attended America’s oldest cancer institution, Roswell Park Cancer Institute (RPCI), Buffalo, USA as pre-doctoral trainee in 2013. At RPCI, he starts to learn basics of mitochondrial apoptosis in cancer cells. He extended his scientific regimen to understand how mitochondrial apoptosis in cancer is associated with chemokines and cytokines, especially CXCL8 in prostate and colon malignancies. After getting a confidence in immunology and tumor biology he got training in bone marrow transplantation and started studies on tumor immunology and immunotherapy. Dr. Kumar moved to University of Illinois at Chicago (UIC) in 2016 and currently, his research area is encompassing role of MAPKs in T cells, B-cells and macrophages functions and its implications in tumor biology and immunotherapy. At UIC, his major focus on discovery of novel immune pathway/s in triple negative breast cancer leading to new diagnostic and therapeutic targets. His dedication in science is reflected by more than 50 peer reviewed publications in international peer reviewed journals and conference proceedings in the very early phase of his career. He has served as a committee member of Asia and the Pacific basin region committee and cells and mediators of allergic inflammation committee of American Academy of Allergy Asthma and Immunology, USA. He is actively involved with European Academy of Allergy and Clinical Immunology, World Allergy Organization and American Association of Cancer Research and other national and international organizations.

Dr. Sandeep Kumar research interests are Immunotoxicology, Tumor immunology, Immune signaling, Immunotherapy